Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

60 Degrees Pharmaceuticals (SXTP) Assets Average (2023 - 2025)

60 Degrees Pharmaceuticals (SXTP) has disclosed Assets Average for 3 consecutive years, with $5.4 million as the latest value for Q3 2025.

  • On a quarterly basis, Assets Average fell 7.46% to $5.4 million in Q3 2025 year-over-year; TTM through Sep 2025 was $5.4 million, a 7.46% decrease, with the full-year FY2024 number at $6.8 million, up 49.14% from a year prior.
  • Assets Average was $5.4 million for Q3 2025 at 60 Degrees Pharmaceuticals, up from $5.1 million in the prior quarter.
  • In the past five years, Assets Average ranged from a high of $8.5 million in Q4 2023 to a low of $5.1 million in Q2 2025.
  • A 3-year average of $6.7 million and a median of $6.4 million in 2024 define the central range for Assets Average.
  • Peak YoY movement for Assets Average: decreased 28.84% in 2024, then fell 7.46% in 2025.
  • 60 Degrees Pharmaceuticals' Assets Average stood at $8.5 million in 2023, then dropped by 22.17% to $6.6 million in 2024, then fell by 17.52% to $5.4 million in 2025.
  • Per Business Quant, the three most recent readings for SXTP's Assets Average are $5.4 million (Q3 2025), $5.1 million (Q2 2025), and $5.9 million (Q1 2025).